Activation of the IGF1R pathway potentially mediates acquired resistance to mutant-selective 3rd-generation EGF receptor tyrosine kinase inhibitors in advanced non-small cell lung cancer
2012 ◽
Vol 12
(11)
◽
pp. 1429-1435
◽
2010 ◽
Vol 26
(2)
◽
pp. 424-431
◽
2017 ◽
Vol 13
(6)
◽
pp. 3067-3074
◽